Annual CFI
$4.76 M
+$61.88 M+108.33%
December 31, 2023
Summary
- As of February 7, 2025, MIST annual cash flow from investing activities is $4.76 million, with the most recent change of +$61.88 million (+108.33%) on December 31, 2023.
- During the last 3 years, MIST annual CFI has risen by +$74.76 million (+106.79%).
- MIST annual CFI is now -93.21% below its all-time high of $70.00 million, reached on December 31, 2021.
Performance
MIST Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$6.48 M
-$3.00 M-31.65%
September 30, 2024
Summary
- As of February 7, 2025, MIST quarterly cash flow from investing activities is $6.48 million, with the most recent change of -$3.00 million (-31.65%) on September 30, 2024.
- Over the past year, MIST quarterly CFI has increased by +$17.34 million (+159.69%).
- MIST quarterly CFI is now -78.37% below its all-time high of $29.97 million, reached on March 31, 2023.
Performance
MIST Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$2.63 M
+$17.34 M+117.84%
September 30, 2024
Summary
- As of February 7, 2025, MIST TTM cash flow from investing activities is $2.63 million, with the most recent change of +$17.34 million (+117.84%) on September 30, 2024.
- Over the past year, MIST TTM CFI has increased by +$28.56 million (+110.12%).
- MIST TTM CFI is now -96.25% below its all-time high of $70.00 million, reached on December 31, 2021.
Performance
MIST TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
MIST Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +108.3% | +159.7% | +110.1% |
| 3 y3 years | +106.8% | -78.4% | +113.7% |
| 5 y5 years | -70.3% | -78.4% | +113.7% |
MIST Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -93.2% | +108.3% | -78.4% | +123.1% | -96.3% | +104.6% |
| 5 y | 5-year | -93.2% | +106.8% | -78.4% | +120.3% | -96.3% | +103.8% |
| alltime | all time | -93.2% | +106.8% | -78.4% | +118.5% | -96.3% | +103.8% |
Milestone Pharmaceuticals Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $6.48 M(-31.6%) | $2.63 M(-117.8%) |
| Jun 2024 | - | $9.48 M(-135.1%) | -$14.71 M(-71.8%) |
| Mar 2024 | - | -$27.01 M(-297.5%) | -$52.23 M(-1198.1%) |
| Dec 2023 | $4.76 M(-108.3%) | $13.68 M(-226.0%) | $4.76 M(-118.3%) |
| Sep 2023 | - | -$10.86 M(-61.3%) | -$25.93 M(-19.3%) |
| Jun 2023 | - | -$28.03 M(-193.5%) | -$32.13 M(+67.7%) |
| Mar 2023 | - | $29.97 M(-276.1%) | -$19.16 M(-66.5%) |
| Dec 2022 | -$57.12 M(-181.6%) | -$17.02 M(-0.2%) | -$57.12 M(+127.5%) |
| Sep 2022 | - | -$17.05 M(+13.2%) | -$25.11 M(-268.1%) |
| Jun 2022 | - | -$15.06 M(+88.2%) | $14.94 M(-70.1%) |
| Mar 2022 | - | -$8.00 M(-153.3%) | $50.00 M(-28.6%) |
| Dec 2021 | $70.00 M | $15.00 M(-34.8%) | $70.00 M(+70.7%) |
| Sep 2021 | - | $23.00 M(+15.0%) | $41.00 M(-783.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2021 | - | $20.00 M(+66.7%) | -$6.00 M(-89.7%) |
| Mar 2021 | - | $12.00 M(-185.7%) | -$58.00 M(-17.1%) |
| Dec 2020 | -$70.00 M(>+9900.0%) | -$14.00 M(-41.7%) | -$70.00 M(+168.2%) |
| Sep 2020 | - | -$24.00 M(-25.0%) | -$26.10 M(-1102.0%) |
| Jun 2020 | - | -$32.00 M(<-9900.0%) | $2.60 M(-778.4%) |
| Mar 2020 | - | $0.00(-100.0%) | -$384.00 K(0.0%) |
| Dec 2019 | -$384.00 K(-102.4%) | $29.90 M(+535.3%) | -$384.00 K(-98.2%) |
| Sep 2019 | - | $4.71 M(-113.4%) | -$21.30 M(-37.4%) |
| Jun 2019 | - | -$34.99 M(-489.4%) | -$34.02 M(-312.7%) |
| Dec 2018 | $16.00 M(-199.8%) | $8.98 M(-212.1%) | $16.00 M(+128.1%) |
| Sep 2018 | - | -$8.02 M(-199.8%) | $7.01 M(-53.3%) |
| Jun 2018 | - | $8.03 M(+14.8%) | $15.03 M(+114.8%) |
| Mar 2018 | - | $7.00 M | $7.00 M |
| Dec 2017 | -$16.02 M | - | - |
FAQ
- What is Milestone Pharmaceuticals annual cash flow from investing activities?
- What is the all time high annual CFI for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals annual CFI year-on-year change?
- What is Milestone Pharmaceuticals quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals quarterly CFI year-on-year change?
- What is Milestone Pharmaceuticals TTM cash flow from investing activities?
- What is the all time high TTM CFI for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals TTM CFI year-on-year change?
What is Milestone Pharmaceuticals annual cash flow from investing activities?
The current annual CFI of MIST is $4.76 M
What is the all time high annual CFI for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high annual cash flow from investing activities is $70.00 M
What is Milestone Pharmaceuticals annual CFI year-on-year change?
Over the past year, MIST annual cash flow from investing activities has changed by +$61.88 M (+108.33%)
What is Milestone Pharmaceuticals quarterly cash flow from investing activities?
The current quarterly CFI of MIST is $6.48 M
What is the all time high quarterly CFI for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high quarterly cash flow from investing activities is $29.97 M
What is Milestone Pharmaceuticals quarterly CFI year-on-year change?
Over the past year, MIST quarterly cash flow from investing activities has changed by +$17.34 M (+159.69%)
What is Milestone Pharmaceuticals TTM cash flow from investing activities?
The current TTM CFI of MIST is $2.63 M
What is the all time high TTM CFI for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high TTM cash flow from investing activities is $70.00 M
What is Milestone Pharmaceuticals TTM CFI year-on-year change?
Over the past year, MIST TTM cash flow from investing activities has changed by +$28.56 M (+110.12%)